548 related articles for article (PubMed ID: 20545613)
21. Genomic and epigenomic cross-talks in the regulatory landscape of miRNAs in breast cancer.
Samantarrai D; Dash S; Chhetri B; Mallick B
Mol Cancer Res; 2013 Apr; 11(4):315-28. PubMed ID: 23360796
[TBL] [Abstract][Full Text] [Related]
22. The involvement of microRNAs in malignant transformation.
Rutnam ZJ; Yang BB
Histol Histopathol; 2012 Oct; 27(10):1263-70. PubMed ID: 22936445
[TBL] [Abstract][Full Text] [Related]
23. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in breast cancer initiation and progression.
Liu H
Cell Mol Life Sci; 2012 Nov; 69(21):3587-99. PubMed ID: 22926415
[TBL] [Abstract][Full Text] [Related]
27. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs as Biomarker for Breast Cancer.
Aggarwal T; Wadhwa R; Gupta R; Paudel KR; Collet T; Chellappan DK; Gupta G; Perumalsamy H; Mehta M; Satija S; Hansbro PM; Dua K; Maurya PK
Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1597-1610. PubMed ID: 32342824
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs and Their Roles in Breast Cancer Bone Metastasis.
Puppo M; Valluru MK; Clézardin P
Curr Osteoporos Rep; 2021 Jun; 19(3):256-263. PubMed ID: 33830428
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of microRNAs in breast cancer.
Chang HT; Li SC; Ho MR; Pan HW; Ger LP; Hu LY; Yu SY; Li WH; Tsai KW
BMC Genomics; 2012; 13 Suppl 7(Suppl 7):S18. PubMed ID: 23281739
[TBL] [Abstract][Full Text] [Related]
33. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
McGuire A; Brown JA; Kerin MJ
Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
[TBL] [Abstract][Full Text] [Related]
34. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics.
Gomarasca M; Maroni P; Banfi G; Lombardi G
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316552
[TBL] [Abstract][Full Text] [Related]
35. Role of microRNA deregulation in breast cancer cell chemoresistance and stemness.
Tekiner TA; Basaga H
Curr Med Chem; 2013; 20(27):3358-69. PubMed ID: 23651304
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of microRNAs in cancer.
Chen PS; Su JL; Hung MC
J Biomed Sci; 2012 Oct; 19(1):90. PubMed ID: 23075324
[TBL] [Abstract][Full Text] [Related]
38. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
39. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
[TBL] [Abstract][Full Text] [Related]
40. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
Naser Al Deen N; Nassar F; Nasr R; Talhouk R
Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
